Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases.
about
Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular diseaseRole of Notch signaling in regulating innate immunity and inflammation in health and diseaseIFN-γ Priming Effects on the Maintenance of Effector Memory CD4(+) T Cells and on Phagocyte Function: Evidences from Infectious DiseasesMechanisms of Memory T Cell Activation and Effective ImmunityInflammatory cytokines in systemic lupus erythematosusThe complex and central role of interferon-γ in graft-versus-host disease and graft-versus-tumor activityRegulation of type I interferon responsesOverlapping, additive and counterregulatory effects of type II and I interferons on myeloid dendritic cell functionsM1 and M2 immune activation in Parkinson's Disease: Foe and ally?Brain endothelial miR-146a negatively modulates T-cell adhesion through repressing multiple targets to inhibit NF-κB activation.Lithium controls central nervous system autoimmunity through modulation of IFN-γ signalingProtein kinase C θ regulates the phenotype of murine CD4+ Th17 cellsCapture Hi-C identifies a novel causal gene, IL20RA, in the pan-autoimmune genetic susceptibility region 6q23Effects of Interferons and Viruses on MetabolismDeacetylation of p53 induces autophagy by suppressing Bmf expressionSTAT6 and STAT1 Pathway Activation in Circulating Lymphocytes and Monocytes as Predictor of Treatment Response in Rheumatoid ArthritisChemokine Receptor Ccr7 Restricts Fatal West Nile Virus EncephalitisThe M1 and M2 paradigm of macrophage activation: time for reassessmentSelective Activation of Type II Interferon Signaling by Zika Virus NS5 Protein.Endometrial receptivity defects and impaired implantation in diabetic NOD mice.Chromatin immunoprecipitation (ChIP) to assay dynamic histone modification in activated gene expression in human cells.FcγRIIIa-Syk Co-signal Modulates CD4+ T-cell Response and Up-regulates Toll-like Receptor (TLR) ExpressionData mining of atherosclerotic plaque transcriptomes predicts STAT1-dependent inflammatory signal integration in vascular disease.Genome-wide assessment of differential translations with ribosome profiling data.Differential Antagonism of Human Innate Immune Responses by Tick-Borne Phlebovirus Nonstructural Proteins.The bacterial pathogen Listeria monocytogenes and the interferon family: type I, type II and type III interferonsElevated suppressor of cytokine signaling-1 (SOCS-1): a mechanism for dysregulated osteoclastogenesis in HIV transgenic ratsIloprost modulates the immune response in systemic sclerosis.Innate immune activity conditions the effect of regulatory variants upon monocyte gene expressionTranscriptomic Analysis on Responses of Murine Lungs to Pasteurella multocida Infection.De novo assembly and transcriptome characterization: novel insights into the natural resistance mechanisms of Microtus fortis against Schistosoma japonicumComparative tissue transcriptomics reveal prompt inter-organ communication in response to local bacterial kidney infection.Is there an association between IFN-γ +874A/T polymorphism and periodontitis susceptibility?: A meta-analysis.What causes alopecia areata?WSX1 expression in tumors induces immune tolerance via suppression of effector immune cells.Pyrin-only protein 2 limits inflammation but improves protection against bacteria.Memory-T-cell-derived interferon-γ instructs potent innate cell activation for protective immunity.Identification of an IL-27/osteopontin axis in dendritic cells and its modulation by IFN-gamma limits IL-17-mediated autoimmune inflammation.Regulation of Mycobacterium-specific mononuclear cell responses by 25-hydroxyvitamin D3.Discovering causal signaling pathways through gene-expression patterns.
P2860
Q26750725-2A2BF809-3683-4AAF-A91D-E692AAFDFF9DQ26764946-CD832FFF-03BC-4D2C-A31C-7486B12D8C89Q26778206-A0D99E56-689E-4EDB-9C7F-4957953208EAQ26795669-FA0CFC67-9C75-4500-8767-76EF40EC7707Q26823647-E7FD0F3B-07B0-4149-B997-07F2F0636D0AQ26851545-8549C71E-5939-4A43-9A3E-B174B507E174Q26853177-F793A9E3-B636-4AB9-976A-C03B49A3E432Q27014714-0E4E82E2-F485-4CFE-AB7F-3E00E1E25B47Q27024667-DB316BA1-7FA7-4DDD-8D75-B71F87A6F924Q27321637-20D1301D-5A9C-47FC-9CE3-48BBA5D8B7C9Q27324211-991E4DC5-CFFE-4DF7-9821-31B8AADE6542Q27334727-399FC610-9C48-459D-97CA-4E410F67D9DBQ28109583-B5D535D9-C5D3-49B3-803A-A81FAD5014B4Q28353943-5C125585-963C-4694-9B9A-BB8BFAE1D3D8Q28510522-E1C28C7F-741D-45EE-A56E-0E00BF235CBCQ28554987-78913007-25E8-45DB-9C52-53621156D5EFQ29198018-AA4C22FE-8FE3-43D6-8BA8-1527FA94A19AQ29615845-DE745D1F-96BB-4839-9737-62C63687619BQ30145653-7AAFC318-0796-48C3-BC62-6C1CCB18B17DQ30418061-39C41FB9-3F72-4154-97BC-43DF07EE31A0Q30425841-85FB8774-28E2-40AA-9838-5C25EFD20617Q30698666-814C14B9-FE24-4841-830F-919841916E95Q30848049-25052EBD-5915-4A13-BAEB-82ABB6488B47Q31067810-D0D26C4A-14C7-491D-B9D6-3A0725287A8DQ33443358-BAA8BC89-8E34-4372-BF18-D36F3D058019Q33563711-62B132B6-63BE-4B64-95D1-8210C610EEB4Q33723186-A75DC899-21BE-4EA6-B5DA-47FB4419A71BQ33772202-AF4734FD-CAB6-4CDC-9135-DDF0053215E5Q33783132-83587542-E6A7-42CC-AA3B-07A54B55A405Q33813222-A879B99F-BB1C-4D05-B3C8-CC1CBABC7CDFQ33815111-F62D2740-CD35-4657-8827-C6070F1930EEQ33825741-991031F9-649E-404C-AEC6-4B1389C91141Q33833878-0C21C2AF-3E06-4E14-8BBF-CD86C4897FE6Q33889367-24E4FBE6-7AFA-4C3C-9685-C58012B3C4A3Q33895262-09CF677F-F998-46F8-BCCD-01A942C7B232Q33908383-FC3FE49A-348F-4478-8ACA-D0BA93BEA374Q33929969-404FCD88-508D-4E1D-A73A-EA9609600FF2Q33953320-13DA7130-9722-4B9A-A47A-AFCA8CF95C6CQ33955263-7B08652A-6158-41F2-9BAB-1C95557497CBQ33957823-8165479C-DE78-413D-AC71-ACEC7521CFEC
P2860
Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cross-regulation of signaling ...... onses and autoimmune diseases.
@en
Cross-regulation of signaling ...... onses and autoimmune diseases.
@nl
type
label
Cross-regulation of signaling ...... onses and autoimmune diseases.
@en
Cross-regulation of signaling ...... onses and autoimmune diseases.
@nl
prefLabel
Cross-regulation of signaling ...... onses and autoimmune diseases.
@en
Cross-regulation of signaling ...... onses and autoimmune diseases.
@nl
P2860
P1433
P1476
Cross-regulation of signaling ...... onses and autoimmune diseases.
@en
P2093
Lionel B Ivashkiv
P2860
P304
P356
10.1016/J.IMMUNI.2009.09.002
P407
P50
P577
2009-10-01T00:00:00Z